TKT and neoplasm: With the help of lipid/calcium/phosphate nanoparticles (LCPNPs), monophosphorylation modification of ACV can successfully modify an anti-herpes simplex virus, thymidine kinase (HSV-TK) (HSV-TK) HSV-TK-dependent antiviral drug, into an anti-tumor drug [27].